Search by Drug Name, NDC or Jcode

    Internal Navigation

    HCPCS Details

    HCPC Q0244
    Short Description Casirivi and imdevi 1200 mg
    Long Description Injection, casirivimab and imdevimab, 1200 mg
    Pricing indicator 54
    Coverage code C
    ASC payment group code
    BETOS2 code O1G
    Action code N
    Type of service V
    Effective date 2021-06-03
    Date Added 2021-06-03

    Drug Details

    • Casirivimab and imdevimab injection is used in certain non-hospitalized adults and children 12 years of age and older who weigh at least 88 pounds (40 kg) and who have certain medical conditions that make them at higher risk for developing severe COVID-19 symptoms, including hospitalization or death:

      • to treat mild to moderate symptoms of COVID-19.

      • to prevent COVID-19 in those who are not fully vaccinated against COVID-19 or who are vaccinated, but have a weakened immune system, or are taking a medication that affects the immune system and who have had close contact or are at high risk of close contact to someone who is infected with the SARS-CoV-2 virus (for example, nursing homes, prisons).

    • Casirivimab and imdevimab are in a class of medications called monoclonal antibodies. They work by blocking the action of a certain natural substance in the body in order to stop the spread of the virus.